Paper4069211
The human met oncogene is related to the tyrosine kinase oncogenes.
Dean M and 7 others. Nature, 1985. Cited by 314 papers, by iCite.
Cite this record
ConductScience Library. The human met oncogene is related to the tyrosine kinase oncogenes. Papers, record 4069211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4069211
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosomes, Human, 6-12 and X | Major topic |
| Oncogene Proteins, Viral | Major topic |
| Oncogenes | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Base Sequence | |
| Chromosome Mapping | |
| Humans | |
| Proto-Oncogene Mas | |
| Receptor, Insulin | |
| Sequence Homology, Nucleic Acid |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 23954 | NCI NIH HHS | United States | R01CA023954 | PubMed and NIH | NIH RePORTER |
| N01-CO-23909 | NCI NIH HHS | United States | N01CO023909 | PubMed and NIH | NIH RePORTER |
Cited by115
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 314 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42575887 | C-MET tyrosine kinase receptor: mechanisms, clinical applications and future perspectives in cancer therapy. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42575887 | PubMed |
| 40924941 | Mechanistic insights into MET exon 14 skipping mutations and their role in tumor progression. | Biochem Soc Trans | 2025 | https://conductscience.org/library/papers/40924941 | PubMed |
| 40599602 | The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma. | Oncol Rev | 2025 | https://conductscience.org/library/papers/40599602 | PubMed |
| 40405976 | Identification and validation of immune-related and inflammation-related genes in endometriosis. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40405976 | PubMed |
| 40251641 | Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies. | Biomark Res | 2025 | https://conductscience.org/library/papers/40251641 | PubMed |
| 40020676 | The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40020676 | PubMed |
| 39582541 | Research progress on the role of bypass activation mechanisms in resistance to tyrosine kinase inhibitors in non-small cell lung cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39582541 | PubMed |
| 38953007 | The rapidly changing field of predictive biomarkers of non-small cell lung cancer. | Pathol Oncol Res | 2024 | https://conductscience.org/library/papers/38953007 | PubMed |
| 38892318 | MET Oncogene Targeting for Cancer Immunotherapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892318 | PubMed |
| 37642355 | Design, synthesis, and biological evaluation of thiazole/thiadiazole carboxamide scaffold-based derivatives as potential c-Met kinase inhibitors for cancer treatment. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/37642355 | PubMed |
| 37169756 | Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37169756 | PubMed |
| 36596785 | Signaling pathways in brain tumors and therapeutic interventions. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36596785 | PubMed |
| 36508072 | Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. | Mol Biomed | 2022 | https://conductscience.org/library/papers/36508072 | PubMed |
| 35370682 | HGF/c-Met: A Key Promoter in Liver Regeneration. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35370682 | PubMed |
| 35326642 | The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35326642 | PubMed |
| 35135556 | Glioma targeted therapy: insight into future of molecular approaches. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35135556 | PubMed |
| 35081970 | Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35081970 | PubMed |
| 34145400 | HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence. | Oncogene | 2021 | https://conductscience.org/library/papers/34145400 | PubMed |
| 33889528 | A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations. | Transl Lung Cancer Res | 2021 | https://conductscience.org/library/papers/33889528 | PubMed |
| 32982167 | Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/32982167 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MET | 4233 | Swiss-Prot's references | https://conductscience.org/library/genes/4233 | NCBI Gene |
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| INSR | 3643 | PubTator's text mining | https://conductscience.org/library/genes/3643 | NCBI Gene |
| SLTM | 79811 | PubTator's text mining | https://conductscience.org/library/genes/79811 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4069211
GET https://conductscience.org/api/papers/v1/4069211/cited_by?page=2